Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

AIMS: Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy. METHODS AND PATIENTS: A total of 768 patients (18–77 years; HbA(...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacra, A R, Tan, G H, Apanovitch, A, Ravichandran, S, List, J, Chen, R
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Late Breaker
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779994/
https://www.ncbi.nlm.nih.gov/pubmed/19614786
http://dx.doi.org/10.1111/j.1742-1241.2009.02143.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779994/
https://www.ncbi.nlm.nih.gov/pubmed/19614786
http://dx.doi.org/10.1111/j.1742-1241.2009.02143.x

Ejemplares similares